Asia-Pacific Viral Vector Purification Market, By Product & Services (Products and Services), Type (Retroviral Vectors, Vaccine Virus, Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentivirus and Other), Workflow (Upstream Processing and Downstream Processing), Purification Technique (Density-Gradient Ultracentrifugation, Ultrafiltration, Precipitation, Two-Phase Extraction Systems and Chromatography), Scale of Operation (Preclinical / Clinical and Commercial), Delivery Method (In Vivo and Ex Vivo), Disease Indication (Cancer, Genetic Disorders, Infectious Diseases, Veterinary Disease and Other), Application (Antisense & RNAi, Gene Therapy, Cell Therapy and Vaccinology), End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO) and Academic/ Research Institutes), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028
Market Analysis and Insights: Asia-Pacific Viral Vector Purification Market
The viral vector purification market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 15.3% in the forecast period of 2021 to 2028 and is expected to reach USD 266.22 million by 2028. Rising demand for viral vectors is acting as a driver for the viral vector purification market
Molecular biologists frequently use viral vectors to deliver genetic material into cells. This procedure can be carried out in vivo (inside a living organism) or in cell culture (in vitro). Viruses have developed specialized molecular mechanisms to transport their genomes efficiently inside the cells they infect. Transduction is the delivery of genes or other genetic material by a vector and infected cells are referred to as transduced.
Emergence of COVID-19 and demand for viral vaccine is boosting the viral vector purification market. Lack of scalability is a restraint for the viral vector purification market. Rising number of infectious disease act as an opportunity for the viral vector purification market. Shortage of skilled personnel is a challenge for the viral vector purification market.
The viral vector purification market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the viral vector purification market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Viral Vector Purification Market Scope and Market Size
The viral vector purification market is categorized into nine notable segments which are based on the product & services, type, workflow, purification technique, scale of operation, delivery method, disease indication, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product & services, the viral vector purification market is segmented into products and services. In 2021, products segment is expected to dominate the viral vector purification market due to availability of diverse range of innovative solutions for vector purification.
- On the basis of type, the viral vector purification market is segmented into retroviral vectors, vaccine virus, adenoviral vectors, adeno-associated viral vectors, lentivirus and other. In 2021, adeno-associated viral vectors segment is expected to dominate the viral vector purification market due to broad range of infectivity of AAV.
- On the basis of workflow, the viral vector purification market is segmented into upstream processing and downstream processing. In 2021, upstream processing segment is expected to dominate the viral vector purification market because the viral vectors produced using this process can be harvested from cells in a short window of time post transfection.
- On the basis of purification technique, the viral vector purification market is segmented into density-gradient ultracentrifugation, ultrafiltration, precipitation, two-phase extraction systems and chromatography. In 2021, chromatography segment is expected to dominate the viral vector purification market because it has been widely used for purification of vaccines and gene therapy vectors.
- On the basis of scale of operation, the viral vector purification market is segmented into preclinical / clinical and commercial. In 2021, preclinical / clinical segment is expected to dominate the viral vector purification market due to rising investment for research and development activities by major healthcare organizations.
- On the basis of delivery method, the viral vector purification market is segmented into in vivo and ex vivo. In 2021, in vivo segment is expected to dominate the viral vector purification market due to its high availability and process reliability.
- On the basis of disease indication, the viral vector purification market is segmented into cancer, genetic disorders, infectious diseases, veterinary disease and other. In 2021, genetic disorders segment is expected to dominate the viral vector purification market owing to the rising incidence and prevalence of genetic disorders.
- On the basis of application, the viral vector purification market is segmented into antisense & RNAi, gene therapy, cell therapy and vaccinology. In 2021, gene therapy segment is expected to dominate the viral vector purification market due to broad range of applications in medical sector.
- On the basis of end user, the viral vector purification market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, contract development and manufacturing organization (CDMO) and academic/ research institutes. In 2021, academic/ research institutes segment is expected to dominate the viral vector purification market due to increasing initiative activities by various healthcare organizations and government bodies to encourage research endeavour.
Asia-Pacific Viral Vector Purification Market Country Level Analysis
Asia-Pacific viral vector purification market is analysed and market size information is provided by the country, product & services, type, workflow, purification technique, scale of operation, delivery method, disease indication, application and end user as referenced above.
The countries covered in the Asia-Pacific viral vector purification market report are Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines and rest of Asia-Pacific.
Asia-Pacific is expected to grow with the fastest CAGR in the forecast period as in the Asia-Pacific’s countries, the demand for viral vector purification is increasing very rapidly due to rapidly increasing population and increasing healthcare expenditure. Japan is expected to dominate in Asia-Pacific viral vector purification market as Japan is one of the leading countries in the Asia-Pacific utilizing advanced viral vector purification products for treatments.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Viral Vector Purification Market
The viral vector purification market also provides you with detailed market analysis for every country growth. Moreover, it provides detail data regarding growth in viral vector purification sales, partnership, acquisition, distribution agreements among the viral vector purification market players of Asia-Pacific region. The data is available for historic period 2011 to 2019.
Competitive Landscape and Viral Vector Purification Market Share Analysis
The viral vector purification market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific viral vector purification market.
The major players covered in the Asia-Pacific viral vector purification market report are Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Sirion-Biotech GmbH, Merck KGaA, Batavia Biosciences B.V., Agilent Technologies, Inc., Addgene, Takara Bio Inc., Thermo Fisher Scientific Inc., uniQure N.V., BioVision Inc., Cytiva (a subsidiary of Danaher) and BIA Separations among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contracts and agreements are also initiated by the companies’ worldwide which are also accelerating the viral vector purification market.
For instance,
- In January 2021, Thermo Fisher Scientific Inc. announced that it has completed the acquisition of Novsep’s viral vector manufacturing business in Belgium which will help the company to further diversify its market.
Collaboration, joint ventures and other strategies by the market players is enhancing the company impression in the viral vector purification market which also provides the benefit for organisation to improve their sales growth.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 RISING DEMAND FOR VIRAL VECTORS
4.1.2 AVAILABILITY OF DIVERSE RANGE OF INNOVATIVE SOLUTIONS FOR VECTOR PURIFICATION
4.1.3 EMERGENCE OF COVID-19 AND DEMAND FOR VACCINE DEVELOPMENT
4.1.4 BENEFITS OF VIRAL VECTORS FOR GENE THERAPY
4.1.5 GROWING USAGE OF AAV VECTORS FOR DELIVERY OF SIRNA IN MAMMALIAN CELLS
4.2 RESTRAINTS
4.2.1 LACK OF SCALABILITY
4.2.2 LIMITATIONS OF DOWNSTREAM PURIFICATION
4.3 OPPORTUNITIES
4.3.1 GROWING CANCER BURDEN WORLDWIDE
4.3.2 RISING NUMBER OF INFECTIOUS DISEASES
4.3.3 GROWING GERIATRIC POPULATION
4.3.4 RISING HEALTH CONSCIOUSNESS AND INCREASING SPENDING ON HEALTHCARE
4.4 CHALLENGES
4.4.1 BIOLOGICAL CHALLENGES
4.4.2 SHORTAGE OF SKILLED PERSONNEL
5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: REGULATIONS
1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES
1.1 OVERVIEW
1.2 PRODUCTS
1.2.1 RESIN
1.2.2 KIT
1.2.3 REAGENT
1.2.4 PREPACKED COLUMN
1.2.5 CASSETTE
1.2.6 CAPSULE
1.2.7 FILTER PLATE
1.3 SERVICES
2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE
2.1 OVERVIEW
2.2 CHROMATOGRAPHY
2.2.1 AFFINITY CHROMATOGRAPHY
2.2.2 ION-EXCHANGE CHROMATOGRAPHY
2.2.3 SIZE-EXCLUSION CHROMATOGRAPHY
2.2.4 HYDROPHILIC INTERACTION CHROMATOGRAPHY
2.3 DENSITY-GRADIENT ULTRACENTRIFUGATION
2.4 ULTRAFILTRATION
2.5 PRECIPITATION
2.6 TWO-PHASE EXTRACTION SYSTEMS
3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE
3.1 OVERVIEW
3.2 ADENO-ASSOCIATED VIRAL VECTORS
3.3 ADENOVIRAL VECTORS
3.3.1 MASTADENOVIRUS
3.3.2 AVIADENOVIRUS
3.3.3 SIADENOVIRUS
3.3.4 ATADENOVIRUS
3.3.5 ICHTADENOVIRUS
3.4 LENTIVIRUS
3.5 RETROVIRAL VECTORS
3.5.1 REPLICATION DEFECTIVE
3.5.2 REPLICATION-COMPETENT
3.6 VACCINE VIRUS
3.7 OTHER
4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW
4.1 OVERVIEW
4.2 UPSTREAM PROCESSING
4.3 DOWNSTREAM PROCESSING
5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION
5.1 OVERVIEW
5.2 PRECLINICAL / CLINICAL
5.3 COMMERCIAL
6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY MODE
6.1 OVERVIEW
6.2 IN VIVO
6.3 EX VIVO
7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION
7.1 OVERVIEW
7.2 GENETIC DISORDERS
7.2.1 THALASSEMIA
7.2.2 CYSTIC FIBROSIS
7.2.3 TAY-SACHS DISEASE
7.2.4 SICKLE CELL ANEMIA
7.2.5 OTHERS
7.3 INFECTIOUS DISEASES
7.3.1 MEASLES VIRUS
7.3.2 VESICULAR STOMATITIS VIRUS
7.3.3 NOVEL ADENOVIRUSES
7.3.4 CYTOMEGALOVIRUS
7.3.5 OTHERS
7.4 VETERINARY DISEASE
7.5 CANCER
7.6 OTHER
8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 GENE THERAPY
8.2.1 RECOMBINANT PROTEIN EXPRESSION
8.2.2 FUNCTIONAL ASSAYS
8.2.3 PROTEIN CHARACTERIZATION
8.2.4 IN VITRO TRANSCRIPTION
8.2.5 OTHERS
8.3 CELL THERAPY
8.4 VACCINOLOGY
8.5 ANTISENSE & RNAI
9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER
9.1 OVERVIEW
9.2 ACADEMIC/ RESEARCH INSTITUTES
9.3 PHARMACEUTICAL COMPANIES
9.4 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO)
9.5 BIOTECHNOLOGY COMPANIES
9.6 CONTRACT RESEARCH ORGANIZATIONS
10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY GEOGRAPHY
10.1 ASIA-PACIFIC
10.1.1 JAPAN
10.1.2 SOUTH KOREA
10.1.3 AUSTRALIA
10.1.4 SINGAPORE
10.1.5 MALAYSIA
10.1.6 THAILAND
10.1.7 INDONESIA
10.1.8 PHILIPPINES
10.1.9 REST OF ASIA-PACIFIC
11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 COMPANY PROFILE
12.1 THERMO FISHER SCIENTIFC INC.
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 CYTIVA (A SUBSIDIARY OF DANAHER)
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 MERCK KGAA
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 AGILENT TECHNOLOGIES, INC.
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 FUJIFILM DIOSYNTH BIOTECHNOLOGIES
12.5.1 COMPANY SNAPSHOT
12.5.2 PRODUCT PORTFOLIO
12.6 ADDGENE
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 ALDEVRON
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 APPLIED BIOLOGICAL MATERIALS INC.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 BIA SEPARATIONS
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 BIO-RAD LABORATORIES, INC.
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENT
12.11 BIOVISION INC.
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 RECENT DEVELOPMENT
12.12 BATAVIA BIOSCIENCES B.V.
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENT
12.13 CREATIVE BIOGENE
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
12.14 CREATIVE BIOLABS
12.14.1 COMPANY SNAPSHOT
12.14.2 SERVICE PORTFOLIO
12.15 IDT BIOLOGIKA GMBH
12.15.1 COMPANY SNAPSHOT
12.15.2 PRODUCT PORTFOLIO
12.15.3 RECENT DEVELOPMENTS
12.16 PROBIOGEN AG
12.16.1 COMPANY SNAPSHOT
12.16.2 PRODUCT PORTFOLIO
12.16.3 RECENT DEVELOPMENTS
12.17 SIRION-BIOTECH GMBH
12.17.1 COMPANY SNAPSHOT
12.17.2 PRODUCT PORTFOLIO
12.17.3 RECENT DEVELOPMENTS
12.18 TAKARA BIO INC.
12.18.1 COMPANY SNAPSHOT
12.18.2 REVENUE ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 RECENT DEVELOPMENTS
12.19 UNIQURE N.V.
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 PRODUCT PORTFOLIO
12.19.4 RECENT DEVELOPMENT
12.2 WAISMAN BIOMANUFACTURING
12.20.1 COMPANY SNAPSHOT
12.20.2 PRODUCT PORTFOLIO
12.20.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC SERVICES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC DENSITY-GRADIENT ULTRACENTRIFUGATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC ULTRAFILTRATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC PRECIPITATION IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC TWO-PHASE EXTRACTION SYSTEMS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC ADENO-ASSOCIATED VIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC LENTIVIRUS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC VACCINE VIRUS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC OTHER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC UPSTREAM PROCESSING IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC DOWNSTREAM PROCESSING IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC PRECLINICAL / CLINICAL IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC COMMERCIAL IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY MODE, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC IN VIVO IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC EX VIVO IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC VETERINARY DISEASE IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC CANCER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC OTHER IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC CELL THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC VACCINOLOGY IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC ANTISENSE & RNAI IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC ACADEMIC/ RESEARCH INSTITUTES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC PHARMACEUTICAL COMPANIES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CDMO) IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC BIOTECHNOLOGY COMPANIES IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN VIRAL VECTOR PURIFICATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 55 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 ASIA-PACIFIC RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 57 ASIA-PACIFIC ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 59 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 60 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 61 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 62 ASIA-PACIFIC GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 63 ASIA-PACIFIC INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 64 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 ASIA-PACIFIC GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 67 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 68 JAPAN PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 69 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 70 JAPAN CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 71 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 72 JAPAN RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 73 JAPAN ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 74 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 75 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 76 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 77 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 78 JAPAN GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 79 JAPAN INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 80 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 JAPAN GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 82 JAPAN VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 83 CHINA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 84 CHINA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 85 CHINA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 86 CHINA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 87 CHINA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 CHINA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 CHINA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 90 CHINA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 91 CHINA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 92 CHINA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 93 CHINA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 94 CHINA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 95 CHINA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 96 CHINA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 97 CHINA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 CHINA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 99 INDIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 100 INDIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 101 INDIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 102 INDIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 103 INDIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 104 INDIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 105 INDIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 INDIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 107 INDIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 108 INDIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 109 INDIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 110 INDIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 111 INDIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 112 INDIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 INDIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 114 INDIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 115 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 116 SOUTH KOREA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 117 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 118 SOUTH KOREA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 119 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 SOUTH KOREA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 SOUTH KOREA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 122 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 123 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 124 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 125 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 126 SOUTH KOREA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 127 SOUTH KOREA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 128 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 129 SOUTH KOREA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 130 SOUTH KOREA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 131 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 132 AUSTRALIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 133 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 134 AUSTRALIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 135 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 136 AUSTRALIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 AUSTRALIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 138 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 139 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 140 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 141 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 142 AUSTRALIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 143 AUSTRALIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 144 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 145 AUSTRALIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 146 AUSTRALIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 147 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 148 SINGAPORE PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 149 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 150 SINGAPORE CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 151 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 152 SINGAPORE RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 153 SINGAPORE ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 154 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 155 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 156 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 157 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 158 SINGAPORE GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 159 SINGAPORE INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 160 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 161 SINGAPORE GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 162 SINGAPORE VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 163 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 164 MALAYSIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 165 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 166 MALAYSIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 167 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 168 MALAYSIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 169 MALAYSIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 170 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 171 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 172 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 173 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 174 MALAYSIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 175 MALAYSIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 176 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 177 MALAYSIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 178 MALAYSIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 179 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 180 THAILAND PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 181 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 182 THAILAND CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 183 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 184 THAILAND RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 185 THAILAND ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 186 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 187 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 188 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 189 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 190 THAILAND GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 191 THAILAND INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 192 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 193 THAILAND GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 194 THAILAND VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 195 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 196 INDONESIA PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 197 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 198 INDONESIA CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 199 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 200 INDONESIA RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 201 INDONESIA ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 202 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 203 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 204 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 205 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 206 INDONESIA GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 207 INDONESIA INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 208 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 209 INDONESIA GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 210 INDONESIA VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 211 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 212 PHILIPPINES PRODUCTS IN VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
TABLE 213 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 214 PHILIPPINES CHROMATOGRAPHY IN VIRAL VECTOR PURIFICATION MARKET, BY PURIFICATION TECHNIQUE, 2019-2028 (USD MILLION)
TABLE 215 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 216 PHILIPPINES RETROVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 217 PHILIPPINES ADENOVIRAL VECTORS IN VIRAL VECTOR PURIFICATION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 218 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY WORKFLOW, 2019-2028 (USD MILLION)
TABLE 219 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY SCALE OF OPERATION, 2019-2028 (USD MILLION)
TABLE 220 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY DELIVERY METHOD, 2019-2028 (USD MILLION)
TABLE 221 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 222 PHILIPPINES GENETIC DISORDERS IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 223 PHILIPPINES INFECTIOUS DISEASES IN VIRAL VECTOR PURIFICATION MARKET, BY DISEASE INDICATION, 2019-2028 (USD MILLION)
TABLE 224 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 225 PHILIPPINES GENE THERAPY IN VIRAL VECTOR PURIFICATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 226 PHILIPPINES VIRAL VECTOR PURIFICATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 227 REST OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION
FIGURE 12 AVAILABILITY OF DIVERSE RANGE OF INNOVATIVE SOLUTIONS FOR VECTOR PURIFICATION IS DRIVING THE ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET
FIGURE 15 ESTIMATED NUMBER OF NEW CASES IN MALE AND FEMALE (ALL AGE GROUP) WORLDWIDE IN 2018
FIGURE 1 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, 2020
FIGURE 2 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, 2021-2028 (USD MILLION)
FIGURE 3 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, CAGR (2021-2028)
FIGURE 4 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 5 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, 2020
FIGURE 6 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, 2021-2028 (USD MILLION)
FIGURE 7 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, CAGR (2021-2028)
FIGURE 8 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY PURIFICATION TECHNIQUE, LIFELINE CURVE
FIGURE 9 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, 2020
FIGURE 10 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, 2021-2028 (USD MILLION)
FIGURE 11 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 12 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 13 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, 2020
FIGURE 14 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, 2021-2028 (USD MILLION)
FIGURE 15 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, CAGR (2021-2028)
FIGURE 16 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY WORKFLOW, LIFELINE CURVE
FIGURE 17 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, 2020
FIGURE 18 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, 2021-2028 (USD MILLION)
FIGURE 19 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, CAGR (2021-2028)
FIGURE 20 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY SCALE OF OPERATION, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, 2020
FIGURE 22 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, 2021-2028 (USD MILLION)
FIGURE 23 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, CAGR (2021-2028)
FIGURE 24 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, 2020
FIGURE 26 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, 2021-2028 (USD MILLION)
FIGURE 27 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, CAGR (2021-2028)
FIGURE 28 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY DISEASE INDICATION, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, 2020
FIGURE 30 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 31 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 32 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, 2020
FIGURE 34 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 35 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, CAGR (2021-2028)
FIGURE 36 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: SNAPSHOT (2020)
FIGURE 38 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2020)
FIGURE 39 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 40 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 41 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: BY TYPE (2021-2028)
FIGURE 42 ASIA-PACIFIC VIRAL VECTOR PURIFICATION MARKET: COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
